Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher John Burns Insider Profile
11 Followers
Christopher John Burns, Managing Director & Chief Executive Officer at Amplia Therapeutics Ltd., holds 3.73M shares in Amplia Therapeutics Ltd. (Ticker: INNMF).
Christopher John Burns Amplia Therapeutics Ltd. (INNMF)Managing Director & Chief Executive Officer
Amplia Therapeutics Ltd. (INNMF)
Managing Director & Chief Executive Officer
Ranked #12,769 out of 99,218 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+71.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher John Burns's holdings
Insider Roles
Managing Director & Chief Executive Officer
Roles that Christopher John Burns holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 21, 2024 - Today
Return:+204.50%
The most profitable trade made by Christopher John Burns
Christopher John Burns's Trading History
List of latest transactions for each holding click on a transaction to see Christopher John Burns's performance on stock
You May Also Like
Christopher John Burns insider profile FAQ
What is the percentage of profitable transactions made by Christopher John Burns?
The percentage of profitable transactions made by Christopher John Burns is 67%.
What is the average return per transaction made by Christopher John Burns?
The average return per transaction made by Christopher John Burns is 71.10%.
What stocks does Christopher John Burns hold?
Christopher John Burns holds: INNMF stocks.
What was Christopher John Burns’s latest transaction?
Christopher John Burns latest transaction was an Uninformative Buy of $36.35K.
What was Christopher John Burns's most profitable transaction?
Christopher John Burns’s most profitable transaction was an Informative Buy of INNMF stock on May 21, 2024. The return on the trade was 204.50%.
What is Christopher John Burns's role in Amplia Therapeutics Ltd.?
Christopher John Burns's role in Amplia Therapeutics Ltd. is Managing Director & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.